Stay updated on Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial

Sign up to get notified when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The website footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-02T11:33:28.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    0.6%
    Check dated 2026-10-26T10:53:49.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T11:51:27.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The site revision label in the footer changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-12T14:12:15.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    New site revision entry v3.7.0 was added to the history, replacing the previous v3.6.6. This reflects an interface/version update in the study history timeline.
    Difference
    0.1%
    Check dated 2026-09-21T21:50:27.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The study record history now shows the latest revision as v3.6.6, replacing the previous v3.6.5. This reflects an update to the ClinicalTrials.gov record display for the nct03836066 page.
    Difference
    0.1%
    Check dated 2026-08-31T17:51:24.000Z thumbnail image

Stay in the know with updates to Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.